Dr. Andriy Krendyukov

Senior executive and leadership responsibilities, acting de-facto as CMO. Immuno-oncology, rare disease, COVID19, innovative biologics. Product Development, Clinical and Medical Affairs Strategy & Operations, Scientific Affairs, Phase I-III Clinical Trials, Product Safety and PV´(including developing safety database, signal detection and DSMB), Pre-Clinical Research & Projects, Regulatory Strategy and Interaction with Competent Authorities (EMA, HTA, PEI), Business Development and Intelligence

Executive and leadership responsibilities, direct report and matrix teams, acting as portfolio/therapeutic areas head. Oncology & nephrology (portfolio), biologics & biosimilars. Product Development, Clinical and Medical Affairs Strategy & Operations, Scientific Affairs, Launches, Phase I-IV Clinical Trials, Product Safety and PV, Regulatory Strategy and Interaction with Competent Authorities (EMA, HTA, FDA), Business Development and Intelligence

Executive leadership position, matrix organization. Dermatology & aesthetic dermatology, neurology, innovative biologics and portfolio of medical devices. Global Medical Affairs and Clinical Education, Scientific and Organizational (Overall) Lead for Annual Experts Meeting (MAEX), Scientific and Clinical Communication, incl. Global Publication Team, Phase III-IV clinical trials and IITs (Dermatology and Neurology), Global and Regional Launches, Market Access. Product safety and PV, Business Development

Head of the Global Brand Team; Global Marketing and Medical Affairs, Marketing and Scientific Training for Executives (IDPS), Regional Commercial Director